FEBS Letters · 2005 · 130 citations · 34 references
Life SciencesBiochemistryNeuroscienceApoptosisNeurodegenerationNeurotoxicologyApoptosis In NeurodegenerationIntrinsic Apoptotic PathwayMitochondrial ToxicityNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersAmyloid ToxicityAmyloid-beta Induced ApoptosisAmyloid-beta-induced NeurotoxicityMitochondrial Apoptosis SignalingMitochondrial Redox StateMitochondrial ResponseRedox Control Of ApoptosisRedox Signaling In Apoptosis
In order to clarify the basis of neuronal toxicity exerted by the shortest active peptides of amyloid beta-protein (Abeta), the toxic effects of Abeta(31-35) and Abeta(25-35) peptides on isolated rat brain mitochondria were investigated. The results show that exposure of isolated rat brain mitochondria to Abeta(31-35) and Abeta(25-35) peptides determines: (i) release of cytochrome c; (ii) mitochondrial swelling and (iii) a significant reduction in mitochondrial oxygen consumption. In contrast, the amplitude of these events resulted attenuated in isolated brain mitochondria exposed to the Abeta(31-35)Met35(OX) in which methionine-35 was oxidized to methionine sulfoxide. The Abeta peptide derivative with norleucine substituting Met-35, i.e., Abeta(31-35)Nle-35, had not effect on any of the biochemical parameters tested. We have further characterized the action of Abeta(31-35) and Abeta(25-35) peptides on neuronal cells. Taken together our result indicate that Abeta(31-35) and Abeta(25-35) peptides in non-aggregated form, i.e., predominantly monomeric, are strongly neurotoxic, having the ability to enter within the cells, determining mitochondrial damage with an evident trigger of apoptotic signals. Such a mechanism of toxicity seems to be dependent by the redox state of methionine-35.
34
Use of an Aqueous Soluble Tetrazolium/Formazan Assay for Cell Growth Assays in Culture
Ann H. Cory, Terence C. Owen, J. A. Barltrop et al. · Cancer Communications · 1991 · 1.5K citations